-
Something wrong with this record ?
Breast and cervical cancer screening attendance among Czech women
A. Altová, I. Kulhánová, L. Brůha, M. Lustigová
Language English Country Czech Republic
Document type Journal Article
Digital library NLK
Source
NLK
Free Medical Journals
from 2004
ProQuest Central
from 2009-03-01 to 6 months ago
Medline Complete (EBSCOhost)
from 2006-03-01 to 6 months ago
Nursing & Allied Health Database (ProQuest)
from 2009-03-01 to 6 months ago
Health & Medicine (ProQuest)
from 2009-03-01 to 6 months ago
Public Health Database (ProQuest)
from 2009-03-01 to 6 months ago
ROAD: Directory of Open Access Scholarly Resources
from 1993
PubMed
34245547
DOI
10.21101/cejph.a6623
Knihovny.cz E-resources
- MeSH
- Early Detection of Cancer MeSH
- Humans MeSH
- Uterine Cervical Neoplasms * MeSH
- Breast Neoplasms * diagnosis MeSH
- Mass Screening MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
OBJECTIVES: The aim of the study was to investigate the variation in breast and cervical cancer screening attendance among Czech women by age and in regions in 2009-2017. METHODS: The data from the health insurance company that covers around 50% of the Czech population were used to calculate age-specific attendance rates and standardized attendance rates by year and region. RESULTS: In 2017, the attendance of all eligible women was 52% in breast cancer screening and 46% in cervical cancer screening. There were differences in attendance among groups of women. Women aged 45-49 had attendance rates in both screenings around 60%, while 39% of women aged 75-79 attended breast cancer screening, and 23% attended cervical cancer screening. In regions, attendance ranged from 38% to 70% in breast cancer screening and from 32% to 55% in cervical cancer screening. CONCLUSIONS: We identified the age-specific differences and regional variation in both breast and cervical cancer screening attendance among Czech women. Those with lower attendance may have a higher risk of dying from breast and cervical cancers. Mitigating this risk should be a priority of public health policies.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21017496
- 003
- CZ-PrNML
- 005
- 20210804081225.0
- 007
- ta
- 008
- 210723s2021 xr bd f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a6623 $2 doi
- 035 __
- $a (PubMed)34245547
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Altová, Anna, $d 1994- $7 xx0262692 $u Department of Demography and Geodemography, Faculty of Science, Charles University, Prague, Czech Republic
- 245 10
- $a Breast and cervical cancer screening attendance among Czech women / $c A. Altová, I. Kulhánová, L. Brůha, M. Lustigová
- 504 __
- $a Literatura
- 520 9_
- $a OBJECTIVES: The aim of the study was to investigate the variation in breast and cervical cancer screening attendance among Czech women by age and in regions in 2009-2017. METHODS: The data from the health insurance company that covers around 50% of the Czech population were used to calculate age-specific attendance rates and standardized attendance rates by year and region. RESULTS: In 2017, the attendance of all eligible women was 52% in breast cancer screening and 46% in cervical cancer screening. There were differences in attendance among groups of women. Women aged 45-49 had attendance rates in both screenings around 60%, while 39% of women aged 75-79 attended breast cancer screening, and 23% attended cervical cancer screening. In regions, attendance ranged from 38% to 70% in breast cancer screening and from 32% to 55% in cervical cancer screening. CONCLUSIONS: We identified the age-specific differences and regional variation in both breast and cervical cancer screening attendance among Czech women. Those with lower attendance may have a higher risk of dying from breast and cervical cancers. Mitigating this risk should be a priority of public health policies.
- 650 12
- $a nádory prsu $x diagnóza $7 D001943
- 650 _2
- $a časná detekce nádoru $7 D055088
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plošný screening $7 D008403
- 650 12
- $a nádory děložního čípku $7 D002583
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kulhánová, Ivana $7 xx0261370 $u Department of Demography and Geodemography, Faculty of Science, Charles University, Prague, Czech Republic $u Department of Social Geography and Regional Development, Faculty of Science, Charles University, Prague, Czech Republic
- 700 1_
- $a Brůha, Lukáš $7 xx0262711 $u Department of Applied Geoinformatics and Cartography, Faculty of Science, Charles University, Prague, Czech Republic
- 700 1_
- $a Lustigová, Michala $7 xx0135529 $u Department of Social Geography and Regional Development, Faculty of Science, Charles University, Prague, Czech Republic $u National Institute of Public Health, Prague, Czech Republic
- 773 0_
- $w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 29, č. 2 (2021), s. 90-95
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34245547 $y Pubmed
- 910 __
- $a ABA008 $b B 1829 $c 562 $y p $z 0
- 990 __
- $a 20210723 $b ABA008
- 991 __
- $a 20210804081222 $b ABA008
- 999 __
- $a ok $b bmc $g 1678443 $s 1137938
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 29 $c 2 $d 90-95 $e 20210630 $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
- LZP __
- $b NLK118 $a Pubmed-20210723
